ÂÜÀòÂÒÂ×

Drew M. has an extensive work experience history in the field of finance and accounting. They currently hold the position of Vice President, FP&A at Zenas BioPharma since July 2022. Prior to this role, Drew served as the Head of FP&A at Zenas BioPharma from October 2021 to July 2022.

Before joining Zenas BioPharma, Drew worked at Orchard Therapeutics as the Vice President, Global FP&A from May 2020 to October 2021. They also held the position of Head of FP&A at Morphic Therapeutic from February 2019 to May 2020.

Earlier in their career, Drew served as the Sr. Director of Financial Planning & Analysis at TESARO from July 2012 to February 2019. They were also a Sr Manager, Finance at AMAG Pharmaceuticals from July 2008 to June 2012.

Before joining AMAG Pharmaceuticals, Drew worked as a Sr Financial Analyst at Oscient Pharmaceuticals from June 2006 to July 2008. They also held the position of Sr Accountant at QAS from 2003 to 2006, and Accountant at Variagenics from 2001 to 2003.

Drew M. attended Merrimack College from 1997 to 2001. However, no specific degree or field of study is mentioned during this period.